IL-13Rα2 Status Predicts GB-13 (IL13.E13K-PE4E) Efficacy in High-Grade Glioma
- DOI
- 10.3390/pharmaceutics14050922
- Published
- 2022-04-24
- Container
- Pharmaceutics
- Publisher
- MDPI AG
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.3390/pharmaceutics14050922,
title = {IL-13Rα2 Status Predicts GB-13 (IL13.E13K-PE4E) Efficacy in High-Grade Glioma},
author = {Julian S. Rechberger and Kendra A. Porath and Liang Zhang and Cody L. Nesvick and Randy S. Schrecengost and Jann N. Sarkaria and David J. Daniels},
year = {2022},
journal = {Pharmaceutics},
doi = {10.3390/pharmaceutics14050922},
url = {https://doi.org/10.3390/pharmaceutics14050922}
}RIS
TY - JOUR TI - IL-13Rα2 Status Predicts GB-13 (IL13.E13K-PE4E) Efficacy in High-Grade Glioma AU - Julian S. Rechberger AU - Kendra A. Porath AU - Liang Zhang AU - Cody L. Nesvick AU - Randy S. Schrecengost AU - Jann N. Sarkaria AU - David J. Daniels PY - 2022 JO - Pharmaceutics DO - 10.3390/pharmaceutics14050922 UR - https://doi.org/10.3390/pharmaceutics14050922 ER -
APA
Rechberger, J. S., Porath, K. A., Zhang, L., Nesvick, C. L., Schrecengost, R. S., Sarkaria, J. N., & Daniels, D. J. (2022). IL-13Rα2 Status Predicts GB-13 (IL13.E13K-PE4E) Efficacy in High-Grade Glioma. Pharmaceutics. https://doi.org/10.3390/pharmaceutics14050922
Source records
- crossref · retrieved 2026-09-27T07:29:18.671Z